Skip to content
Subscriber Only

Brandicourt as Sanofi Chief to Focus on Taking Drugs to U.S.

Updated on

Olivier Brandicourt, whose track record includes the introduction of the best-selling drug in history, takes the helm at Sanofi with the mandate of bringing new drugs to the U.S. after missteps led to his predecessor’s ouster.

Brandicourt, the 59-year-old head of Bayer AG’s health-care division, is “a very good fit” for Sanofi and “has the experience of the portfolio businesses we have,” Sanofi’s Chairman Serge Weinberg said in an interview. “A lot will be about launches, not only in 2015,” and the U.S. “is very high on the priority list,” Weinberg said.